Pfizer anti-covid drug

Get your science fix here: research, quackery, activism and all the rest
Post Reply
User avatar
bjn
Stummy Beige
Posts: 2915
Joined: Wed Sep 25, 2019 4:58 pm
Location: London

Pfizer anti-covid drug

Post by bjn » Wed Dec 15, 2021 7:43 pm

Pfizer just released more data on their new anti-covid drug Paxlovid, and it looks really good.
Ars Technica wrote:In the high-risk group trial, there's now data from over 2,000 participants. And the results are in line with what was seen earlier. Less than 1 percent of the people who received the drug were hospitalized, compared to 6.5 percent of the placebo control group. Nobody receiving the drug died, while nine in the placebo group did. The drug appeared roughly equally effective when administered as late as five days after symptom onset.

Overall, there was a 94 percent reduction in relative risk among those over the age of 65. There's also evidence the drug reduced viral load, although this was a complicated analysis that's difficult to evaluate based on the information in a press release.

Among the moderate-risk patients, data is only available on 673 participants so far. But the numbers here also look good: a 70 percent reduction in hospitalization and no deaths in the treatment group. No one died in either the treatment or placebo groups, and the rate of hospitalizations was lower in the placebo group than in the placebo group of the high-risk trial, as you'd expect.

Post Reply